{"id":"nct:NCT05202509","kind":"trial","title":"Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease","authors":["NewAmsterdam Pharma"],"author_count":1,"year":2022,"published":"2022-01-21","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT05202509","source_url":"https://clinicaltrials.gov/study/NCT05202509","archive_url":"https://space-kitty.com/papers/nct:NCT05202509","updated":"2024-06-04","pmid":null,"pmcid":null,"openalex_id":null,"pdf_url":null,"abstract":"This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD) who are not adequately controlled despite maximally tolerated lipid-lowering therapy.","abstract_license":"ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters","license":"ClinicalTrials.gov terms (attribution, processing date, modifications noted)","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Atherosclerotic Cardiovascular Disease"],"details":{"acronym":"PREVAIL","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE3","study_type":"INTERVENTIONAL","enrollment":9541,"sponsor":"NewAmsterdam Pharma","conditions":["Atherosclerotic Cardiovascular Disease"],"interventions":["DRUG: Obicetrapib","DRUG: Placebo"],"start_date":"2022-02-07","start_date_type":"ACTUAL","primary_completion_date":"2026-11-01","has_results":false,"data_source":"ClinicalTrials.gov","data_processed":"2026-10-29T09:00:05","modifications":"selected fields only; whitespace normalized; brief summary truncated to 2,000 characters"},"provenance":"clinicaltrials","attribution":"Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}